Allergan, Inc. (AGN) - Product Pipeline Analysis, 2015 Update

Date: March 4, 2015
Pages: 41
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF7A4F3C64CEN
Leaflet:

Download PDF Leaflet

Allergan, Inc. (AGN) - Product Pipeline Analysis, 2015 Update
Summary

Allergan, Inc. (Allergan) is a global healthcare company. It develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. The major customers of the company include wholesalers, drug stores, pharmacies, opticians, merchandisers, food stores, hospitals, and medical practitioners among others. Allergan is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Allergan, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • Allergan, Inc. Company Snapshot
    Allergan, Inc. Company Overview
    Key Information
    Allergan, Inc. Pipeline Products and Clinical Trials Overview
    Allergan, Inc. – Pipeline Analysis Overview
    Business Description
    Key Facts
    Allergan, Inc. - Major Products and Services
    Allergan, Inc. Pipeline Products by Development Stage
    Allergan, Inc. Clinical Trials by Trial Status
    Allergan, Inc. Pipeline Products Overview
    JUVEDERM Volbella
    JUVEDERM Volbella Product Overview
    JUVEDERM Volbella Clinical Trial
    JUVEDERM VOLIFT
    JUVEDERM VOLIFT Product Overview
    Juvederm VOLUMA XC
    Juvederm VOLUMA XC Product Overview
    Juvederm VOLUMA XC Clinical Trial
    LiRIS
    LiRIS Product Overview
    LiRIS Clinical Trial
    NOVADUR Intravitreal Implant
    NOVADUR Intravitreal Implant Product Overview
    Ozuredex Intravitreal Implant - Diabetic Macular Edema
    Ozuredex Intravitreal Implant - Diabetic Macular Edema Product Overview
    Allergan, Inc. - Key Competitors
    Allergan, Inc. - Key Employees
    Allergan, Inc. - Key Employee Biographies
    Allergan, Inc. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    Allergan, Inc., Recent Developments
    Feb 27, 2015: FDA Approves Allergan's NATRELLE INSPIRA Round Gel-Filled Breast Implants
    Feb 04, 2015: Allergan Reports Fourth Quarter 2014 Operating Results
    Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold
    Dec 17, 2014: COTCHETT, PITRE & McCARTHY Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014
    Nov 14, 2014: Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
    Nov 12, 2014: Allergan Board of Directors Announces Approval of Amendments to Company's Bylaws
    Nov 12, 2014: FDA Approves New Style of Allergan's NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implant X Style
    Nov 12, 2014: FDA Approves New Style of Allergan's NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implant L Style
    Nov 04, 2014: Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit Against Valeant & Pershing Square
    Oct 29, 2014: Allergan Canada Launches a 3D JUVEDERM Visualization iPad App Powered by ModiFace
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Allergan, Inc., Key Facts
    Allergan, Inc. Pipeline Products and Clinical Trials Overview
    Allergan, Inc. Pipeline Products by Equipment Type
    Allergan, Inc. Pipeline Products by Indication
    Allergan, Inc. Clinical Trials by Trial Status
    Allergan, Inc., Key Facts
    Allergan, Inc., Major Products and Services
    Allergan, Inc. Number of Pipeline Products by Development Stage
    Allergan, Inc. Pipeline Products Summary by Development Stage
    Allergan, Inc. Clinical Trials by Trial Status
    Allergan, Inc. Clinical Trials Summary
    JUVEDERM Volbella - Product Status
    JUVEDERM Volbella - Product Description
    JUVEDERM Volbella - A Prospective, Open Label Study Evaluating JUVEDERM VOLBELLA with Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area
    JUVEDERM Volbella - A Randomized, Evaluator-blinded, Comparative Study of the Safety and Efficacy of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine
    JUVEDERM VOLIFT - Product Status
    JUVEDERM VOLIFT - Product Description
    Juvederm VOLUMA XC - Product Status
    Juvederm VOLUMA XC - Product Description
    Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin
    Juvederm VOLUMA XC - Voluma Treatment of HIV Facial Lipoatrophy
    LiRIS - Product Status
    LiRIS - Product Description
    LiRIS - A Phase 2a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS in Women With Interstitial Cystitis Followed by an Open Label Extension
    NOVADUR Intravitreal Implant - Product Status
    NOVADUR Intravitreal Implant - Product Description
    Ozuredex Intravitreal Implant - Diabetic Macular Edema - Product Status
    Ozuredex Intravitreal Implant - Diabetic Macular Edema - Product Description
    Allergan, Inc., Key Employees
    Allergan, Inc., Key Employee Biographies
    Allergan, Inc., Other Locations
    Allergan, Inc., Subsidiaries

    LIST OF FIGURES

    Allergan, Inc. Pipeline Products by Equipment Type
    Allergan, Inc. Pipeline Products by Development Stage
    Allergan, Inc. Clinical Trials by Trial Status
    Skip to top


    Ask Your Question

    Allergan, Inc. (AGN) - Product Pipeline Analysis, 2015 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: